McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Dave Schulte Named as One of GrowthCap’s Top 25 Healthcare Investors of 2024

by McKesson Ventures | May 1, 2024 | Media Coverage

On May 1, 2024, growth investor and executive insights company GrowthCap named McKesson Ventures’ Managing Director Dave Schulte as one of its Top 25 Healthcare Investors of 2024. The list, published annually and founded in 2021, seeks to acknowledge individuals who...

World’s Best Digital Health Companies 2024

by McKesson Ventures | Apr 25, 2024 | Portfolio News

Newsweek’s list of the World’s Best Digital Health Companies is a collaboration with Statista, and the inaugural rankings were released on April 25, 2024. The goal of the list is to inform potential patients and medical providers on which products, services, and data...

SSM Health partners with Inbound Health to offer in-home advanced care to patients

by McKesson Ventures | Apr 24, 2024 | Portfolio News, Press Releases

Inbound Health and SSM Health have partnered up to offer post-hospital in-home health care services to patients. The SSM Health at Home program – Recovery Care at Home – will apply to certain patients who are ready to be discharged but who still need services...

CancerIQ CEO Feyi Ayodele Named to Modern Healthcare’s 2024 Innovators List

by McKesson Ventures | Apr 9, 2024 | Press Releases

On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and...

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

by McKesson Ventures | Apr 8, 2024 | Press Releases

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...
Page 5 of 142« First«...34567...102030...»Last »

Recent Posts

  • Saama Unveils Industry-first AI-Powered Tables, Listings, and Figures (TLF) Analyzer to Transform Clinical Study Reporting
  • McKesson Ventures Announces Expansion Into Growth Equity and Welcomes Peter Lafer as Head of Growth Investing
  • Oath Surgical Raises $24M to Build the First Surgeon-Owned, AI-Powered Surgical System
  • Lumata Health Improves Patient Adherence to Vision-Saving Treatments by Alleviating Barriers to Care
  • Saama Introduces Modular and Adaptive AI Agents For Clinical Innovation
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104
USA

 

Contact Us

In the News

Reimagine Care and Memorial Hermann Health System Unveil Expanded On-Demand Cancer Care Partnership

HarmonyCares Secures $200M to Expand Access to In-Home Primary Care

ChatRWD™ Beta from Atropos Health Exceeds Big Tech LLMs on Physician Trust and Ability to Answer Questions Completely with High-Quality Evidence in New Study

Atropos Health Raises $33M To Scale The Automation Of High-Quality, Personalized Real-World Evidence Leveraging Generative AI

©2025 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
  • Follow